SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-000722
Filing Date
2022-02-02
Accepted
2022-02-02 17:15:02
Documents
18
Period of Report
2022-01-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20220127x8k.htm   iXBRL 8-K 74513
2 EX-10.1 krbp-20220127xex10d1.htm EX-10.1 71727
3 EX-10.2 krbp-20220127xex10d2.htm EX-10.2 75474
4 EX-10.3 krbp-20220127xex10d3.htm EX-10.3 108467
5 EX-99.1 krbp-20220127xex99d1.htm EX-99.1 30984
6 GRAPHIC krbp-20220127xex10d1001.jpg GRAPHIC 6336
7 GRAPHIC krbp-20220127xex10d3002.jpg GRAPHIC 6443
  Complete submission text file 0001558370-22-000722.txt   576538

Data Files

Seq Description Document Type Size
8 EX-101.SCH krbp-20220127.xsd EX-101.SCH 3046
9 EX-101.LAB krbp-20220127_lab.xml EX-101.LAB 16584
10 EX-101.PRE krbp-20220127_pre.xml EX-101.PRE 10537
12 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20220127x8k_htm.xml XML 5027
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 22584743
SIC: 2836 Biological Products, (No Diagnostic Substances)